Leptin and mucosal immunity
Author(s) -
Nicole M. Mackey-Lawrence,
William A. Petri
Publication year - 2012
Publication title -
mucosal immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.596
H-Index - 101
eISSN - 1935-3456
pISSN - 1933-0219
DOI - 10.1038/mi.2012.40
Subject(s) - leptin , leptin receptor , biology , immunity , innate immune system , immune system , immunology , intestinal epithelium , stat3 , acquired immune system , receptor , stat protein , signal transduction , epithelium , genetics , endocrinology , obesity
Enhanced susceptibility to infection has long been recognized in children with congenital deficiency of leptin or its receptor. Studies in mice have demonstrated that leptin deficiency affects both the innate and acquired immune systems. Here, we review recent studies that demonstrate the impact on immunity of a common non-synonomous polymorphism of the leptin receptor. In a Bangladesh cohort of children, the presence of two copies of the ancestral Q223 allele was significantly associated with resistance to amebiasis. Children and mice with at least one copy of the leptin receptor 223R mutation were more susceptible to amebic colitis. Leptin signaling in the intestinal epithelium and downstream STAT3 (signal transducer and activator of transcription 3) and SHP2 (Src homology phosphatase 2) signaling were required for protection in the murine model of amebic colitis. Murine models have also implicated leptin in protection from other infections, including Mycobacterium tuberculosis, Klebsiella pneumoniae, and Streptococcus pneumoniae. Thus, the role of leptin signaling in infectious disease and specifically leptin-mediated protection of the intestinal epithelium will be the focus of this review.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom